Trends in Cardiovascular Medicine
Volume 18, Issue 5 , Pages 163-172, July 2008

Myocardial Protection by Nitrite: Evidence That This Reperfusion Therapeutic Will Not Be Lost in Translation

  • Shashank S. Sinha

      Affiliations

    • Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA
    • Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Bethesda, MD 20814, USA
  • ,
  • Sruti Shiva

      Affiliations

    • Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA
  • ,
  • Mark T. Gladwin

      Affiliations

    • Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA
    • Critical Care Medicine Department, National Institutes of Health, Bethesda, MD 20892, USA
    • Corresponding Author InformationAddress correspondence to: Mark T. Gladwin, National Institutes of Health Building 10-CRC, Room 5-5140 10 Center Dr, MSC 1454 Bethesda, MD 20892, USA. Tel.: (+1) 301 435 2310

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Gladwin is listed as a coinventor on a National Institutes of Health government patent application for the use of NaNO2 for cardiovascular indications..

PII: S1050-1738(08)00099-6

doi:10.1016/j.tcm.2008.05.001

Trends in Cardiovascular Medicine
Volume 18, Issue 5 , Pages 163-172, July 2008